BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Penn Epigenetics - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Penn Epigenetics
X-ORIGINAL-URL:https://epigenetics.upenndev.pendari.com
X-WR-CALDESC:Events for Penn Epigenetics
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250206T160000
DTEND;TZID=America/New_York:20250206T170000
DTSTAMP:20240823T121344Z
CREATED:20240823T121344Z
LAST-MODIFIED:20240823T121344Z
UID:13336-1738857600-1738861200@epigenetics.upenndev.pendari.com
SUMMARY:H. Courtney Hodges\, Ph.D. (Baylor University) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:H. Courtney Hodges\, Ph.D.\nAssociate Professor\nDepartment of Molecular and Cellular Biology\nBaylor College of Medicine\nThe Hodges Lab \nPlease join us on Thursday\, February 6\, 2025\, as we welcome H. Courtney Hodges\, Ph.D.\, Associate Professor at Baylor College of Medicine. Dr. Hodges will give a talk titled “Disordered interaction modules that impart specificity for chromatin and transcription.” Immediately following Dr. Hodges\, we will hear from Krista Budinich\, Graduate Student in the Wan Lab\, who will give a talk titled\, “RNA enhances the function of oncogenic transcriptional condensates formed by a mutant chromatin reader.” This event will take place in Smilow 9-146 and on zoom from 4PM – 5PM. \nAbout the H. Courtney Hodges\, Ph.D. \n\n\n\n\n\n\n\n\n\n\nResearch in the Hodges lab focuses on gene regulation in cancer and normal cells. We use interdisciplinary approaches\, including epigenomics\, live-cell imaging\, and chemical biology\, to reveal new mechanisms related to chromatin and transcription. We are especially excited by emerging therapeutics related to cancer epigenetics and other areas with translational impact.
URL:https://epigenetics.upenndev.pendari.com/event/h-courtney-hodges-ph-d-bayloruniversity-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2024/08/Hodges_photo-resized.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250206T160000
DTEND;TZID=America/New_York:20250206T170000
DTSTAMP:20240823T121344Z
CREATED:20240823T121344Z
LAST-MODIFIED:20240823T121344Z
UID:14766-1738857600-1738861200@epigenetics.upenndev.pendari.com
SUMMARY:H. Courtney Hodges\, Ph.D. (Baylor University) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:H. Courtney Hodges\, Ph.D.\nAssociate Professor\nDepartment of Molecular and Cellular Biology\nBaylor College of Medicine\nThe Hodges Lab \nPlease join us on Thursday\, February 6\, 2025\, as we welcome H. Courtney Hodges\, Ph.D.\, Associate Professor at Baylor College of Medicine. Dr. Hodges will give a talk titled “Disordered interaction modules that impart specificity for chromatin and transcription.” Immediately following Dr. Hodges\, we will hear from Krista Budinich\, Graduate Student in the Wan Lab\, who will give a talk titled\, “RNA enhances the function of oncogenic transcriptional condensates formed by a mutant chromatin reader.” This event will take place in Smilow 9-146 and on zoom from 4PM – 5PM. \nAbout the H. Courtney Hodges\, Ph.D. \n\n\n\n\n\n\n\n\n\n\nResearch in the Hodges lab focuses on gene regulation in cancer and normal cells. We use interdisciplinary approaches\, including epigenomics\, live-cell imaging\, and chemical biology\, to reveal new mechanisms related to chromatin and transcription. We are especially excited by emerging therapeutics related to cancer epigenetics and other areas with translational impact.
URL:https://epigenetics.upenndev.pendari.com/event/h-courtney-hodges-ph-d-bayloruniversity-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2024/08/Hodges_photo-resized.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250109T160000
DTEND;TZID=America/New_York:20250109T170000
DTSTAMP:20240823T120717Z
CREATED:20240823T120717Z
LAST-MODIFIED:20240823T120717Z
UID:13331-1736438400-1736442000@epigenetics.upenndev.pendari.com
SUMMARY:Catherine J. Peña\, Ph.D. (Princeton University) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Catherine J. Peña\, Ph.D.\nAssistant Professor\nPrinceton Neuroscience Institute\nPrinceton University\nThe Peña Lab \nPlease join us on Thursday\, January 9\, 2025\, as we welcome Catherine J. Peña\, Ph.D.\, Assistant Professor at Princeton University. This event will take place in Smilow 9-146 and on zoom from 4PM – 5PM. \n\n\n\n\n\n\n\nThe broad goal of the Peña Lab is to understand mechanistically how early life experiences are encoded and maintained into adulthood to have long-lasting impact on behavior. The lab is currently focused on understanding how early life stress increases sensitivity to subsequent stress. This research is translationally motivated by the robust clinical finding that child maltreatment and other forms of early life stress increase the lifetime risk of depression and other mood\, anxiety\, and drug disorders. Studies in humans and animals suggest that early life stress sensitizes individuals to stress later in life\, leading to a first appearance or synergistic worsening of depression-like symptoms after additional stress.
URL:https://epigenetics.upenndev.pendari.com/event/catherine-j-pena-ph-d-princeton-university-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2024/08/Pena-scaled-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250109T160000
DTEND;TZID=America/New_York:20250109T170000
DTSTAMP:20240823T120717Z
CREATED:20240823T120717Z
LAST-MODIFIED:20240823T120717Z
UID:14765-1736438400-1736442000@epigenetics.upenndev.pendari.com
SUMMARY:Catherine J. Peña\, Ph.D. (Princeton University) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Catherine J. Peña\, Ph.D.\nAssistant Professor\nPrinceton Neuroscience Institute\nPrinceton University\nThe Peña Lab \nPlease join us on Thursday\, January 9\, 2025\, as we welcome Catherine J. Peña\, Ph.D.\, Assistant Professor at Princeton University. This event will take place in Smilow 9-146 and on zoom from 4PM – 5PM. \n\n\n\n\n\n\n\nThe broad goal of the Peña Lab is to understand mechanistically how early life experiences are encoded and maintained into adulthood to have long-lasting impact on behavior. The lab is currently focused on understanding how early life stress increases sensitivity to subsequent stress. This research is translationally motivated by the robust clinical finding that child maltreatment and other forms of early life stress increase the lifetime risk of depression and other mood\, anxiety\, and drug disorders. Studies in humans and animals suggest that early life stress sensitizes individuals to stress later in life\, leading to a first appearance or synergistic worsening of depression-like symptoms after additional stress.
URL:https://epigenetics.upenndev.pendari.com/event/catherine-j-pena-ph-d-princeton-university-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2024/08/Pena-scaled-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241107T160000
DTEND;TZID=America/New_York:20241107T170000
DTSTAMP:20240823T115944Z
CREATED:20240823T115944Z
LAST-MODIFIED:20240823T115944Z
UID:13329-1730995200-1730998800@epigenetics.upenndev.pendari.com
SUMMARY:Vikram Paralkar\, M.D. (University of Pennsylvania) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Vikram Paralkar\, M.D.\nAssistant Professor of Medicine\nUniversity of Pennsylvania\nThe Paralkar Lab \nPlease join us on Thursday\, November 7\, 2024\, for a Special Edition Monthly Seminar featuring Dr. Vikram Paralkar. Dr. Paralkar is an Assistant Professor of Medicine at the University of Pennsylvania.  This event will take place in Smilow 10-146 and on zoom from 4PM – 5PM. \n\n\n\n\nResearch in the Paralkar Lab spans the spectrum from human patient sample studies and mouse models to cutting-edge molecular biology tools\, high-throughput sequencing approaches\, and novel computational algorithms\, all with the goal of gaining insight into how the transcription of coding genes and noncoding ribosomal DNA genes is regulated in hematopoietic stem cells\, myeloid progenitors\, and in leukemia.
URL:https://epigenetics.upenndev.pendari.com/event/vikram-paralkar-m-d-university-of-pennsylvania-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/01/Paralkar-Vikram-2-resized.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241107T160000
DTEND;TZID=America/New_York:20241107T170000
DTSTAMP:20240823T115944Z
CREATED:20240823T115944Z
LAST-MODIFIED:20240823T115944Z
UID:14764-1730995200-1730998800@epigenetics.upenndev.pendari.com
SUMMARY:Vikram Paralkar\, M.D. (University of Pennsylvania) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Vikram Paralkar\, M.D.\nAssistant Professor of Medicine\nUniversity of Pennsylvania\nThe Paralkar Lab \nPlease join us on Thursday\, November 7\, 2024\, for a Special Edition Monthly Seminar featuring Dr. Vikram Paralkar. Dr. Paralkar is an Assistant Professor of Medicine at the University of Pennsylvania.  This event will take place in Smilow 10-146 and on zoom from 4PM – 5PM. \n\n\n\n\nResearch in the Paralkar Lab spans the spectrum from human patient sample studies and mouse models to cutting-edge molecular biology tools\, high-throughput sequencing approaches\, and novel computational algorithms\, all with the goal of gaining insight into how the transcription of coding genes and noncoding ribosomal DNA genes is regulated in hematopoietic stem cells\, myeloid progenitors\, and in leukemia.
URL:https://epigenetics.upenndev.pendari.com/event/vikram-paralkar-m-d-university-of-pennsylvania-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/01/Paralkar-Vikram-2-resized.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240912T160000
DTEND;TZID=America/New_York:20240912T170000
DTSTAMP:20240823T115316Z
CREATED:20240823T115316Z
LAST-MODIFIED:20240823T115316Z
UID:13323-1726156800-1726160400@epigenetics.upenndev.pendari.com
SUMMARY:Hao Yuan Kueh\, Ph.D. (University of Washington) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Hao Yuan Kueh\, Ph.D.\nAssociate Professor\nDepartment of Bioengineering\nUniversity of Washington\nThe Kueh Lab \nPlease join us on Thursday\, September 12\, 2024\, as we welcome Dr. Hao Yuan Kueh\, Associate Professor of Bioengineering at the University of Washington. Dr. Kueh will be giving a talk titled\, “Understanding and engineering immune cell fate control circuits.” This event will take place in Smilow 10-146 and on zoom from 4PM – 5PM. \nThe immune system protects the body against a wide array of threats\, ranging from viruses to bacteria to cancer.  These versatile defense capabilities are upheld by a collection of immune cell types\, each of which can sense and mount responses tailored towards distinct types of threats. \nThe Kueh Lab seeks to elucidate how immune cells fate decisions\, both to develop from stem cells\, and to mount effective responses to challenges.  Immune cells utilize circuits of interacting genes and proteins to sense signals and execute cell state transitions.  To understand how these signaling and gene regulatory circuits work\, we use powerful reporter systems and quantitative long-term imaging to follow circuit activity in single cells.  We also use cutting-edge single-cell genomics and genome engineering techniques to define their molecular parts and architecture\, and use mathematical modeling to test and predict their functional performance.  Through this work\, we aim to lay foundations to rationally program immune cells to fight cancer and other life threatening diseases.
URL:https://epigenetics.upenndev.pendari.com/event/hao-yuan-kueh-ph-d-university-of-washington-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2024/08/kueh-headshot-003.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240912T160000
DTEND;TZID=America/New_York:20240912T170000
DTSTAMP:20240823T115316Z
CREATED:20240823T115316Z
LAST-MODIFIED:20240823T115316Z
UID:14763-1726156800-1726160400@epigenetics.upenndev.pendari.com
SUMMARY:Hao Yuan Kueh\, Ph.D. (University of Washington) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Hao Yuan Kueh\, Ph.D.\nAssociate Professor\nDepartment of Bioengineering\nUniversity of Washington\nThe Kueh Lab \nPlease join us on Thursday\, September 12\, 2024\, as we welcome Dr. Hao Yuan Kueh\, Associate Professor of Bioengineering at the University of Washington. Dr. Kueh will be giving a talk titled\, “Understanding and engineering immune cell fate control circuits.” This event will take place in Smilow 10-146 and on zoom from 4PM – 5PM. \nThe immune system protects the body against a wide array of threats\, ranging from viruses to bacteria to cancer.  These versatile defense capabilities are upheld by a collection of immune cell types\, each of which can sense and mount responses tailored towards distinct types of threats. \nThe Kueh Lab seeks to elucidate how immune cells fate decisions\, both to develop from stem cells\, and to mount effective responses to challenges.  Immune cells utilize circuits of interacting genes and proteins to sense signals and execute cell state transitions.  To understand how these signaling and gene regulatory circuits work\, we use powerful reporter systems and quantitative long-term imaging to follow circuit activity in single cells.  We also use cutting-edge single-cell genomics and genome engineering techniques to define their molecular parts and architecture\, and use mathematical modeling to test and predict their functional performance.  Through this work\, we aim to lay foundations to rationally program immune cells to fight cancer and other life threatening diseases.
URL:https://epigenetics.upenndev.pendari.com/event/hao-yuan-kueh-ph-d-university-of-washington-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2024/08/kueh-headshot-003.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240620T160000
DTEND;TZID=America/New_York:20240620T170000
DTSTAMP:20230816T160948Z
CREATED:20230816T160948Z
LAST-MODIFIED:20230816T160948Z
UID:12639-1718899200-1718902800@epigenetics.upenndev.pendari.com
SUMMARY:Lamia Wahba\, Ph.D. (Rockefeller Institute) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Lamia Wahba\, Ph.D.\nAssistant Professor\nThe Rockefeller University\nThe Wahba Lab \nDr. Wahba did her graduate work at the Carnegie Institute’s Dept of Embryology\, located on the Hopkins campus. There she worked on R-loops in budding yeast under the mentorship of Douglas Koshland. For her postdoc she moved to Andy Fire’s lab at Stanford to study small RNA systems in the free-living nematode Caenorhabditis elegans. She joined Rockefeller as an assistant professor in 2023.      \nThe Wahba lab seeks to understand the role of nongenetic inheritance mechanisms in disease and evolutionary processes by dissecting the processes and parameters influencing it\, the biological functions impacted\, and their physiological relevance. Research in the lab builds on Wahba’s previous findings about the role of small RNAs and their protein partners\, Argonautes\, in the transgenerational maintenance of the germline’s immortal character. In most metazoans\, Argonaute/sRNA systems are central to the transgenerational inheritance of gene regulation programs\, but a full mechanistic understanding of initiation and inheritance determinants remains under investigation. \nUsing the free-living nematode C. elegans as a model system\, Wahba’s work has found that some heritable sRNAs propagate through self-perpetuating amplification cycles\, a strategy that allows for the indefinite spread of silencing signals across generations but risks overamplifying them. To limit the potentially dire consequences of sRNA overamplification\, Wahba identified the piRNA pathway (involving a second type of Argonaute/sRNA ribonucleoprotein) as an essential negative modulator of it. In the absence of piRNAs\, worms progressively lose fertility over multiple generations until they become completely sterile\, the result of genes targeted by endogenous Argonautes/sRNAs succumbing to perpetual and inappropriate transgenerational silencing. \nThe roles Argonautes/sRNAs play in maintaining germline mortality highlight the potent nature of nongenetic inheritance\, and the existence of molecular machineries dedicated to its active limitation and regulation. By delineating the mechanistic principles underlying acquisition and inheritance of nongenetic information\, the Wahba lab’s ultimate hope is to address a fundamental question facing researchers across many biological fields: whether it is time to revamp the framework for inheritance to incorporate transmission of molecular factors that transcend DNA sequences. \nHosted by Colin Conine\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/lamia-wahba-ph-d-rockefeller-institute-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/DSC5575_148764.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240620T160000
DTEND;TZID=America/New_York:20240620T170000
DTSTAMP:20230816T160948Z
CREATED:20230816T160948Z
LAST-MODIFIED:20230816T160948Z
UID:14739-1718899200-1718902800@epigenetics.upenndev.pendari.com
SUMMARY:Lamia Wahba\, Ph.D. (Rockefeller Institute) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Lamia Wahba\, Ph.D.\nAssistant Professor\nThe Rockefeller University\nThe Wahba Lab \nDr. Wahba did her graduate work at the Carnegie Institute’s Dept of Embryology\, located on the Hopkins campus. There she worked on R-loops in budding yeast under the mentorship of Douglas Koshland. For her postdoc she moved to Andy Fire’s lab at Stanford to study small RNA systems in the free-living nematode Caenorhabditis elegans. She joined Rockefeller as an assistant professor in 2023.      \nThe Wahba lab seeks to understand the role of nongenetic inheritance mechanisms in disease and evolutionary processes by dissecting the processes and parameters influencing it\, the biological functions impacted\, and their physiological relevance. Research in the lab builds on Wahba’s previous findings about the role of small RNAs and their protein partners\, Argonautes\, in the transgenerational maintenance of the germline’s immortal character. In most metazoans\, Argonaute/sRNA systems are central to the transgenerational inheritance of gene regulation programs\, but a full mechanistic understanding of initiation and inheritance determinants remains under investigation. \nUsing the free-living nematode C. elegans as a model system\, Wahba’s work has found that some heritable sRNAs propagate through self-perpetuating amplification cycles\, a strategy that allows for the indefinite spread of silencing signals across generations but risks overamplifying them. To limit the potentially dire consequences of sRNA overamplification\, Wahba identified the piRNA pathway (involving a second type of Argonaute/sRNA ribonucleoprotein) as an essential negative modulator of it. In the absence of piRNAs\, worms progressively lose fertility over multiple generations until they become completely sterile\, the result of genes targeted by endogenous Argonautes/sRNAs succumbing to perpetual and inappropriate transgenerational silencing. \nThe roles Argonautes/sRNAs play in maintaining germline mortality highlight the potent nature of nongenetic inheritance\, and the existence of molecular machineries dedicated to its active limitation and regulation. By delineating the mechanistic principles underlying acquisition and inheritance of nongenetic information\, the Wahba lab’s ultimate hope is to address a fundamental question facing researchers across many biological fields: whether it is time to revamp the framework for inheritance to incorporate transmission of molecular factors that transcend DNA sequences. \nHosted by Colin Conine\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/lamia-wahba-ph-d-rockefeller-institute-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/DSC5575_148764.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240509T160000
DTEND;TZID=America/New_York:20240509T170000
DTSTAMP:20230816T160031Z
CREATED:20230816T160031Z
LAST-MODIFIED:20230816T160031Z
UID:12635-1715270400-1715274000@epigenetics.upenndev.pendari.com
SUMMARY:Eneda Toska\, Ph.D. (Johns Hopkins) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Eneda Toska\, Ph.D.\nAssistant Professor of Oncology\nJohns Hopkins School of Medicine\nThe Toska Lab \nDr. Toska joined the Kimmel Cancer Center as an Assistant Professor of Oncology in the Cancer Invasion and Metastasis Program (CIM)\, in close collaboration with the Women’s Malignancies Disease Group. She also was appointed to a secondary faculty position in the Bloomberg School of Public Health Department of Biochemistry and Molecular Biology (BMB)\, with membership in the BMB Ph.D. program. \nDr. Toska graduated cum laude with a bachelor’s degree in Biology and Chemistry from Nazareth College of Rochester; received her master’s degree from the University at Buffalo\, magna cum laude; and earned her doctorate from the University at Buffalo\, summa cum laude; completing her postdoctoral work with Dr. Jose Baselga at Memorial Sloan Kettering (MSK) and after a senior research scientist role with Dr. Maurizio Scaltriti at MSK. Dr. Toska has been awarded the Breast Cancer Research Alliance Young Investigator Award\, a grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy\, a K22 Transition to Independence Award\, a grant from the Innovation in Cancer Informatics\, and has been selected as a 2021 AACR NextGen Star. \n\nThe Toska Lab’s research focus is centered on elucidating the role that transcriptional and epigenetic regulators play in normal and cancer development\, and therapeutic response. They are passionate about asking clinically relevant questions and translating basic laboratory findings into therapeutic applications to benefit cancer patients while at the same time providing new insights into the fundamental mechanisms of how epigenetic regulators regulate transcription and dictate cell identity. To achieve these goals\, the Toska lab aims to undertake a multidisciplinary approach integrating biochemistry\, cell signaling\, genomics\, and epigenomics at bulk and single-cell level\, organoid technology\, and mouse genetics to study the fundamental processes by which epigenetic regulators regulate transcription\, cross-talk with signaling pathways\, and have the ability to drive transformation and dictate therapeutic response in nuclear receptor-dependent cancers. \n\nHosted by Liling Wang\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/eneda-toska-ph-d-johns-hopkins-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/Eneda-Toska_J852794-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240509T160000
DTEND;TZID=America/New_York:20240509T170000
DTSTAMP:20230816T160031Z
CREATED:20230816T160031Z
LAST-MODIFIED:20230816T160031Z
UID:14738-1715270400-1715274000@epigenetics.upenndev.pendari.com
SUMMARY:Eneda Toska\, Ph.D. (Johns Hopkins) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Eneda Toska\, Ph.D.\nAssistant Professor of Oncology\nJohns Hopkins School of Medicine\nThe Toska Lab \nDr. Toska joined the Kimmel Cancer Center as an Assistant Professor of Oncology in the Cancer Invasion and Metastasis Program (CIM)\, in close collaboration with the Women’s Malignancies Disease Group. She also was appointed to a secondary faculty position in the Bloomberg School of Public Health Department of Biochemistry and Molecular Biology (BMB)\, with membership in the BMB Ph.D. program. \nDr. Toska graduated cum laude with a bachelor’s degree in Biology and Chemistry from Nazareth College of Rochester; received her master’s degree from the University at Buffalo\, magna cum laude; and earned her doctorate from the University at Buffalo\, summa cum laude; completing her postdoctoral work with Dr. Jose Baselga at Memorial Sloan Kettering (MSK) and after a senior research scientist role with Dr. Maurizio Scaltriti at MSK. Dr. Toska has been awarded the Breast Cancer Research Alliance Young Investigator Award\, a grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy\, a K22 Transition to Independence Award\, a grant from the Innovation in Cancer Informatics\, and has been selected as a 2021 AACR NextGen Star. \n\nThe Toska Lab’s research focus is centered on elucidating the role that transcriptional and epigenetic regulators play in normal and cancer development\, and therapeutic response. They are passionate about asking clinically relevant questions and translating basic laboratory findings into therapeutic applications to benefit cancer patients while at the same time providing new insights into the fundamental mechanisms of how epigenetic regulators regulate transcription and dictate cell identity. To achieve these goals\, the Toska lab aims to undertake a multidisciplinary approach integrating biochemistry\, cell signaling\, genomics\, and epigenomics at bulk and single-cell level\, organoid technology\, and mouse genetics to study the fundamental processes by which epigenetic regulators regulate transcription\, cross-talk with signaling pathways\, and have the ability to drive transformation and dictate therapeutic response in nuclear receptor-dependent cancers. \n\nHosted by Liling Wang\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/eneda-toska-ph-d-johns-hopkins-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/Eneda-Toska_J852794-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240411T160000
DTEND;TZID=America/New_York:20240411T170000
DTSTAMP:20230816T155523Z
CREATED:20230816T155523Z
LAST-MODIFIED:20230816T155523Z
UID:12630-1712851200-1712854800@epigenetics.upenndev.pendari.com
SUMMARY:Glen Liszczak\, Ph.D. (UT Southwestern) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Glen Liszczak\, Ph.D.\nAssistant Professor\nUT Southwestern Medical Center\nThe Liszczak Lab \nGlen Liszczak is an Assistant Professor in the Department of Biochemistry at the University of Texas Southwestern Medical Center.  He received his B.S. in Chemistry and Biology from Ramapo College of New Jersey and his Ph.D. in Chemistry from the University of Pennsylvania at the Wistar Institute under the supervision of Dr. Ronen Marmorstein.  As a graduate student\, Glen used X-ray crystallography and other biochemical and biophysical tools to determine the molecular basis for catalysis and substrate specificity exhibited by various protein-modifying enzymes. \nIn 2013\, Glen joined the laboratory of Professor Tom Muir as a postdoctoral fellow at Princeton University where he employed a wide array of chemical biology techniques\, including protein semisynthesis and intracellular protein delivery\, to delineate epigenetic mechanisms and their misregulation in cancer.  During his postdoctoral studies\, Glen combined protein semi-synthesis with high-throughput biochemistry and cellular biology to study proteins that interact with the genome and regulate gene expression. \nIn 2018\, Glen joined the faculty at UTSW as an Endowed Scholar.  His lab integrates chemical and biological approaches to understand the biochemical mechanisms through which enigmatic mutations and aberrant protein post-translational modification cascades lead to disease phenotypes.  Current research topics in the lab include epigenetics\, chromatin structure\, transcriptional regulation\, protein and nucleic acid trafficking\, and protein post-translational modifications such as mono- and poly-ADP-ribosylation.  Our work has uncovered key mechanisms underlying cancer development\, neurodegeneration\, and other developmental abnormalities. \nThroughout his career Glen has been the recipient of numerous awards for his research\, including the Dr. Monica H.M. Shander Memorial Fellowship\, a Ruth L. Kirschstein National Research Service Award\, a Cancer Prevention Research Institute of Texas (CPRIT) Recruitment of First-Time\, Tenure-Track Faculty Member Award\, a UT System Rising STARs Award\, and an American Heart Association Career Development Award. \nHosted by Erica Korb\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/glen-liszczak-ph-d-ut-southwestern-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/glen.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240411T160000
DTEND;TZID=America/New_York:20240411T170000
DTSTAMP:20230816T155523Z
CREATED:20230816T155523Z
LAST-MODIFIED:20230816T155523Z
UID:14737-1712851200-1712854800@epigenetics.upenndev.pendari.com
SUMMARY:Glen Liszczak\, Ph.D. (UT Southwestern) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Glen Liszczak\, Ph.D.\nAssistant Professor\nUT Southwestern Medical Center\nThe Liszczak Lab \nGlen Liszczak is an Assistant Professor in the Department of Biochemistry at the University of Texas Southwestern Medical Center.  He received his B.S. in Chemistry and Biology from Ramapo College of New Jersey and his Ph.D. in Chemistry from the University of Pennsylvania at the Wistar Institute under the supervision of Dr. Ronen Marmorstein.  As a graduate student\, Glen used X-ray crystallography and other biochemical and biophysical tools to determine the molecular basis for catalysis and substrate specificity exhibited by various protein-modifying enzymes. \nIn 2013\, Glen joined the laboratory of Professor Tom Muir as a postdoctoral fellow at Princeton University where he employed a wide array of chemical biology techniques\, including protein semisynthesis and intracellular protein delivery\, to delineate epigenetic mechanisms and their misregulation in cancer.  During his postdoctoral studies\, Glen combined protein semi-synthesis with high-throughput biochemistry and cellular biology to study proteins that interact with the genome and regulate gene expression. \nIn 2018\, Glen joined the faculty at UTSW as an Endowed Scholar.  His lab integrates chemical and biological approaches to understand the biochemical mechanisms through which enigmatic mutations and aberrant protein post-translational modification cascades lead to disease phenotypes.  Current research topics in the lab include epigenetics\, chromatin structure\, transcriptional regulation\, protein and nucleic acid trafficking\, and protein post-translational modifications such as mono- and poly-ADP-ribosylation.  Our work has uncovered key mechanisms underlying cancer development\, neurodegeneration\, and other developmental abnormalities. \nThroughout his career Glen has been the recipient of numerous awards for his research\, including the Dr. Monica H.M. Shander Memorial Fellowship\, a Ruth L. Kirschstein National Research Service Award\, a Cancer Prevention Research Institute of Texas (CPRIT) Recruitment of First-Time\, Tenure-Track Faculty Member Award\, a UT System Rising STARs Award\, and an American Heart Association Career Development Award. \nHosted by Erica Korb\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/glen-liszczak-ph-d-ut-southwestern-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/glen.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240307T160000
DTEND;TZID=America/New_York:20240307T170000
DTSTAMP:20230816T155304Z
CREATED:20230816T155304Z
LAST-MODIFIED:20230816T155304Z
UID:12626-1709827200-1709830800@epigenetics.upenndev.pendari.com
SUMMARY:Hume Stroud\, Ph.D. (UT Southwestern) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Hume Stroud\, Ph.D.\nAssistant Professor\nUT Southwestern Medical Center\nThe Stroud Lab \nHume Stroud received his B.A. from Cornell University. He completed his Ph.D. at the University of California\, Los Angeles\, where he worked with Dr. Steven E. Jacobsen to study the epigenetic regulation of transposons in plants. He then performed his postdoctoral research at Harvard Medical School where he worked with Dr. Michael E. Greenberg to study transcriptional programs controlling neuronal development. In 2021\, he joined UT Southwestern as an Assistant Professor. \nThe Stroud lab investigates epigenome regulation in nervous system development\, health\, and disease. \nHosted by Zhaolan (Joe) Zhou\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/hume-stroud-ph-d-ut-southwestern-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/port_stroud_hume.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240307T160000
DTEND;TZID=America/New_York:20240307T170000
DTSTAMP:20230816T155304Z
CREATED:20230816T155304Z
LAST-MODIFIED:20230816T155304Z
UID:14736-1709827200-1709830800@epigenetics.upenndev.pendari.com
SUMMARY:Hume Stroud\, Ph.D. (UT Southwestern) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Hume Stroud\, Ph.D.\nAssistant Professor\nUT Southwestern Medical Center\nThe Stroud Lab \nHume Stroud received his B.A. from Cornell University. He completed his Ph.D. at the University of California\, Los Angeles\, where he worked with Dr. Steven E. Jacobsen to study the epigenetic regulation of transposons in plants. He then performed his postdoctoral research at Harvard Medical School where he worked with Dr. Michael E. Greenberg to study transcriptional programs controlling neuronal development. In 2021\, he joined UT Southwestern as an Assistant Professor. \nThe Stroud lab investigates epigenome regulation in nervous system development\, health\, and disease. \nHosted by Zhaolan (Joe) Zhou\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/hume-stroud-ph-d-ut-southwestern-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/port_stroud_hume.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240208T160000
DTEND;TZID=America/New_York:20240208T170000
DTSTAMP:20230816T154927Z
CREATED:20230816T154927Z
LAST-MODIFIED:20230816T154927Z
UID:12622-1707408000-1707411600@epigenetics.upenndev.pendari.com
SUMMARY:Efsun Arda\, Ph.D. (NCI) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:H. Efsun Arda\, Ph.D.\nStadtman Investigator\nLaboratory of Receptor Biology and Gene Expression\nNCI/CCR\nThe Arda Lab \nH. Efsun Arda obtained her Ph.D. from University of Massachusetts Medical School. During her doctorate training in Dr. Marian Walhout’s group\, she studied gene regulatory networks that pertain to the metabolism of the model organism\, C. elegans. She uncovered a set of metabolic genes that are sensitive to the nutrient content of C. elegans bacterial diet. \nDriven by her interest in gene regulatory networks and developmental biology\, Dr. Arda joined the laboratory of Dr. Seung Kim at Stanford University for her postdoctoral training. As a JDRF fellow\, she developed cell sorting methods to purify primary pancreatic cells from children and adults\, and used RNA sequencing to reveal hundreds of genes that are differentially regulated during the first 10 years of human lifespan\, several of which are linked by association studies to diabetes risk. To understand how pancreatic cell type-specific gene expression programs are controlled at the genomic level\, she then combined cell sorting with robust genomic techniques\, like ATAC-Seq to delineate the regulatory chromatin landscape of human pancreatic cell types. This work revealed thousands of putative enhancer regions that explain cell type-specific gene expression in the human pancreas. Recently\, she has been characterizing the cell lineages that give rise to human pancreas using single-cell methods. \n\n\nThe pancreas is a vital organ containing hormone-producing cells organized into islets of Langerhans\, whose crucial function is to regulate blood glucose levels. Improper regulation of blood glucose leads to diabetes mellitus\, a disease that affects more than 10% of the U.S. population. Further\, uncontrolled growth of pancreatic cells leads to pancreatic ductal adenocarcinoma\, which ranks 4th among cancer-related deaths in the U.S. To understand the molecular anomalies that lead to organ dysfunction and disease\, it is crucial to define how the information encoded in the human genome is used at the cellular level to establish tissue and organ systems. The research goals of the Arda Lab are to delineate the gene regulatory networks that control the development\, expansion and function of human pancreatic cells. We combine cutting-edge genomic approaches with use of primary human cells\, stem cell and genome-editing technologies to build comprehensive maps of regulatory genomes governing the establishment and growth of human pancreatic cell lineages. \n\n\nHosted by Melike Lakadamyali\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/efsun-arda-ph-d-nci-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/efsun_arda_-_235px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240208T160000
DTEND;TZID=America/New_York:20240208T170000
DTSTAMP:20230816T154927Z
CREATED:20230816T154927Z
LAST-MODIFIED:20230816T154927Z
UID:14735-1707408000-1707411600@epigenetics.upenndev.pendari.com
SUMMARY:Efsun Arda\, Ph.D. (NCI) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:H. Efsun Arda\, Ph.D.\nStadtman Investigator\nLaboratory of Receptor Biology and Gene Expression\nNCI/CCR\nThe Arda Lab \nH. Efsun Arda obtained her Ph.D. from University of Massachusetts Medical School. During her doctorate training in Dr. Marian Walhout’s group\, she studied gene regulatory networks that pertain to the metabolism of the model organism\, C. elegans. She uncovered a set of metabolic genes that are sensitive to the nutrient content of C. elegans bacterial diet. \nDriven by her interest in gene regulatory networks and developmental biology\, Dr. Arda joined the laboratory of Dr. Seung Kim at Stanford University for her postdoctoral training. As a JDRF fellow\, she developed cell sorting methods to purify primary pancreatic cells from children and adults\, and used RNA sequencing to reveal hundreds of genes that are differentially regulated during the first 10 years of human lifespan\, several of which are linked by association studies to diabetes risk. To understand how pancreatic cell type-specific gene expression programs are controlled at the genomic level\, she then combined cell sorting with robust genomic techniques\, like ATAC-Seq to delineate the regulatory chromatin landscape of human pancreatic cell types. This work revealed thousands of putative enhancer regions that explain cell type-specific gene expression in the human pancreas. Recently\, she has been characterizing the cell lineages that give rise to human pancreas using single-cell methods. \n\n\nThe pancreas is a vital organ containing hormone-producing cells organized into islets of Langerhans\, whose crucial function is to regulate blood glucose levels. Improper regulation of blood glucose leads to diabetes mellitus\, a disease that affects more than 10% of the U.S. population. Further\, uncontrolled growth of pancreatic cells leads to pancreatic ductal adenocarcinoma\, which ranks 4th among cancer-related deaths in the U.S. To understand the molecular anomalies that lead to organ dysfunction and disease\, it is crucial to define how the information encoded in the human genome is used at the cellular level to establish tissue and organ systems. The research goals of the Arda Lab are to delineate the gene regulatory networks that control the development\, expansion and function of human pancreatic cells. We combine cutting-edge genomic approaches with use of primary human cells\, stem cell and genome-editing technologies to build comprehensive maps of regulatory genomes governing the establishment and growth of human pancreatic cell lineages. \n\n\nHosted by Melike Lakadamyali\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/efsun-arda-ph-d-nci-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/efsun_arda_-_235px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240111T160000
DTEND;TZID=America/New_York:20240111T170000
DTSTAMP:20230816T154430Z
CREATED:20230816T154430Z
LAST-MODIFIED:20230816T154430Z
UID:12617-1704988800-1704992400@epigenetics.upenndev.pendari.com
SUMMARY:Justus Kebschull\, Ph.D. (Johns Hopkins) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Justus Kebschull\, Ph.D.\nAssistant Professor\, Biomedical Engineering\nJohns Hopkins University\nThe Kebschull Lab \nDr. Kebschull grew up in Germany and received his BA and MSci from the University of Cambridge\, UK in 2011. He pursued his PhD in Tony Zador’s lab at CSHL where he developed DNA sequencing-based tools for brain mapping. In 2017 he joined Liqun Luo’s lab at Stanford University as a postdoctoral fellow\, working on the evolution of the cerebellar nuclei\, before coming to JHU in 2021. \n\n\n\n\n\n\n\n\n\n\nHis research aims to understand the structure and function of the brain. To do so\, his lab takes a comparative approach and engineers molecular\, viral\, and sequencing technologies to measure neuronal connectivity networks and gene expression at scale in disease models and a wide range of vertebrates. He developed the first barcode sequencing-based approaches to map neuronal connectivity\, increasing throughput of single-neuron mapping by orders of magnitude and opening the door to single-cell comparative connectomics. His lab complements these barcoding approaches by in situ sequencing of barcodes and genes. Leveraging these technologies\, they ask questions including: How do new brain regions and connections evolve to support new computations? What are the organizing principles and fundamental circuit motifs of the vertebrate brain? And how do drugs of abuse and neurodevelopmental disorders break these principles? His work is highly interdisciplinary\, residing at the interface of molecular engineering\, neuroscience\, synthetic and evolutionary biology\, genomics\, virology\, and computational biology. \n\n\n\n\n\n\n\n\n\n\nHosted by Liz Heller\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/justus-kebschull-ph-d-johns-hopkins-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/Justus-Kebschull-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240111T160000
DTEND;TZID=America/New_York:20240111T170000
DTSTAMP:20230816T154430Z
CREATED:20230816T154430Z
LAST-MODIFIED:20230816T154430Z
UID:14734-1704988800-1704992400@epigenetics.upenndev.pendari.com
SUMMARY:Justus Kebschull\, Ph.D. (Johns Hopkins) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Justus Kebschull\, Ph.D.\nAssistant Professor\, Biomedical Engineering\nJohns Hopkins University\nThe Kebschull Lab \nDr. Kebschull grew up in Germany and received his BA and MSci from the University of Cambridge\, UK in 2011. He pursued his PhD in Tony Zador’s lab at CSHL where he developed DNA sequencing-based tools for brain mapping. In 2017 he joined Liqun Luo’s lab at Stanford University as a postdoctoral fellow\, working on the evolution of the cerebellar nuclei\, before coming to JHU in 2021. \n\n\n\n\n\n\n\n\n\n\nHis research aims to understand the structure and function of the brain. To do so\, his lab takes a comparative approach and engineers molecular\, viral\, and sequencing technologies to measure neuronal connectivity networks and gene expression at scale in disease models and a wide range of vertebrates. He developed the first barcode sequencing-based approaches to map neuronal connectivity\, increasing throughput of single-neuron mapping by orders of magnitude and opening the door to single-cell comparative connectomics. His lab complements these barcoding approaches by in situ sequencing of barcodes and genes. Leveraging these technologies\, they ask questions including: How do new brain regions and connections evolve to support new computations? What are the organizing principles and fundamental circuit motifs of the vertebrate brain? And how do drugs of abuse and neurodevelopmental disorders break these principles? His work is highly interdisciplinary\, residing at the interface of molecular engineering\, neuroscience\, synthetic and evolutionary biology\, genomics\, virology\, and computational biology. \n\n\n\n\n\n\n\n\n\n\nHosted by Liz Heller\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/justus-kebschull-ph-d-johns-hopkins-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/Justus-Kebschull-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231207T160000
DTEND;TZID=America/New_York:20231207T170000
DTSTAMP:20230816T153939Z
CREATED:20230816T153939Z
LAST-MODIFIED:20230816T153939Z
UID:12614-1701964800-1701968400@epigenetics.upenndev.pendari.com
SUMMARY:Pedro Rocha\, Ph.D. (NIH) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Pedro Rocha\, Ph.D.\nStadtman Investigator\nUnit on Genome Structure and Regulation\nNICH/DIR\nThe Rocha Lab \nDr. Rocha studied Microbiology and Genetics in Portugal\, at Lisbon University\, and graduated in 2005. He then moved to Germany for his PhD where he worked in the lab of Heiner Schrewe at the Max-Planck Institute for Molecular Genetics in Berlin\, studying the role of transcriptional co-regulatory complexes during mouse development\, as part of a Marie Curie-sponsored international consortium. For his postdoctoral training\, Dr. Rocha moved the United States and joined the lab of Jane Skok at New York University\, to explore multiple ways by which nuclear organization maintains genomic integrity. His lab at NIH\, started in May of 2018\, focuses on understanding how the mechanisms that fold the genome contribute to regulation of gene expression and cell-fate decisions. \nHosted by Rajan Jain\, M.D.
URL:https://epigenetics.upenndev.pendari.com/event/pedro-rocha-ph-d-nih-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/png:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/Pedro_Rocha.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231207T160000
DTEND;TZID=America/New_York:20231207T170000
DTSTAMP:20230816T153939Z
CREATED:20230816T153939Z
LAST-MODIFIED:20230816T153939Z
UID:14733-1701964800-1701968400@epigenetics.upenndev.pendari.com
SUMMARY:Pedro Rocha\, Ph.D. (NIH) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Pedro Rocha\, Ph.D.\nStadtman Investigator\nUnit on Genome Structure and Regulation\nNICH/DIR\nThe Rocha Lab \nDr. Rocha studied Microbiology and Genetics in Portugal\, at Lisbon University\, and graduated in 2005. He then moved to Germany for his PhD where he worked in the lab of Heiner Schrewe at the Max-Planck Institute for Molecular Genetics in Berlin\, studying the role of transcriptional co-regulatory complexes during mouse development\, as part of a Marie Curie-sponsored international consortium. For his postdoctoral training\, Dr. Rocha moved the United States and joined the lab of Jane Skok at New York University\, to explore multiple ways by which nuclear organization maintains genomic integrity. His lab at NIH\, started in May of 2018\, focuses on understanding how the mechanisms that fold the genome contribute to regulation of gene expression and cell-fate decisions. \nHosted by Rajan Jain\, M.D.
URL:https://epigenetics.upenndev.pendari.com/event/pedro-rocha-ph-d-nih-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/png:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/Pedro_Rocha.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231109T160000
DTEND;TZID=America/New_York:20231109T170000
DTSTAMP:20230807T163126Z
CREATED:20230807T163126Z
LAST-MODIFIED:20230807T163126Z
UID:12603-1699545600-1699549200@epigenetics.upenndev.pendari.com
SUMMARY:Xiao Wang\, Ph.D. (MIT) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Xiao Wang\, Ph.D.\nThomas D. and Virginia Cabot Assistant Professor of Chemistry\nCore Member of the Broad Institute of MIT and Harvard\nThe Wang Lab \nXiao Wang is a core institute member of the Broad Institute of MIT and Harvard and an assistant professor in the Department of Chemistry at MIT. She started her lab in 2019 to develop and apply new chemical\, biophysical\, and genomic tools to better understand brain function and dysfunction at the molecular level. \nWang joined the MIT and Broad after conducting postdoctoral research at Stanford University with Professor Karl Deisseroth\, where she was a fellow of the Life Sciences Research Foundation. At Stanford\, she developed comprehensive methods for analyzing RNA in intact tissues that merge sequencing with imaging\, in order to reveal the locations of various cell types in the brain. \nWang received her B.S. in chemistry and molecular engineering from Peking University in 2010\, where she studied with Professor Jian Pei and helped develop fluorescent organic materials. She received her Ph.D. in chemistry from the University of Chicago in 2015\, where she elucidated the cellular functions of RNA modifications with Professor Chuan He. \nHosted by Yanxiang Deng\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/xiao-wang-ph-d-mit-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/IMG_4492-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231109T160000
DTEND;TZID=America/New_York:20231109T170000
DTSTAMP:20230807T163126Z
CREATED:20230807T163126Z
LAST-MODIFIED:20230807T163126Z
UID:14732-1699545600-1699549200@epigenetics.upenndev.pendari.com
SUMMARY:Xiao Wang\, Ph.D. (MIT) - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Xiao Wang\, Ph.D.\nThomas D. and Virginia Cabot Assistant Professor of Chemistry\nCore Member of the Broad Institute of MIT and Harvard\nThe Wang Lab \nXiao Wang is a core institute member of the Broad Institute of MIT and Harvard and an assistant professor in the Department of Chemistry at MIT. She started her lab in 2019 to develop and apply new chemical\, biophysical\, and genomic tools to better understand brain function and dysfunction at the molecular level. \nWang joined the MIT and Broad after conducting postdoctoral research at Stanford University with Professor Karl Deisseroth\, where she was a fellow of the Life Sciences Research Foundation. At Stanford\, she developed comprehensive methods for analyzing RNA in intact tissues that merge sequencing with imaging\, in order to reveal the locations of various cell types in the brain. \nWang received her B.S. in chemistry and molecular engineering from Peking University in 2010\, where she studied with Professor Jian Pei and helped develop fluorescent organic materials. She received her Ph.D. in chemistry from the University of Chicago in 2015\, where she elucidated the cellular functions of RNA modifications with Professor Chuan He. \nHosted by Yanxiang Deng\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/xiao-wang-ph-d-mit-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/08/IMG_4492-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230608T140000
DTEND;TZID=America/New_York:20230608T150000
DTSTAMP:20230526T134259Z
CREATED:20230526T134259Z
LAST-MODIFIED:20230526T134259Z
UID:12509-1686232800-1686236400@epigenetics.upenndev.pendari.com
SUMMARY:Bluma Lesch\, M.D.\, Ph.D. (Yale) & Jordan Harris - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Bluma Lesch\, M.D.\, Ph.D.\nAssistant Professor | Department of Genetics\nYale University School of Medicine\nThe Lesch Lab \n“Modeling intergenerational epigenetic inheritance of disease phenotypes in mice” \nTrainee Talk:\nJordan Harris\nMD/PhD Candidate\nKambayashi Lab \n“The microbiota and immune system transgenerationally promote phenotypic diversity in offspring” \nHosted by Colin Conine\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/bluma-lesch-m-d-ph-d-yale-jordan-harris-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/png:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/05/YSM3819_0336_B_Lesch-MS_2-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230608T140000
DTEND;TZID=America/New_York:20230608T150000
DTSTAMP:20230526T134259Z
CREATED:20230526T134259Z
LAST-MODIFIED:20230526T134259Z
UID:14724-1686232800-1686236400@epigenetics.upenndev.pendari.com
SUMMARY:Bluma Lesch\, M.D.\, Ph.D. (Yale) & Jordan Harris - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Bluma Lesch\, M.D.\, Ph.D.\nAssistant Professor | Department of Genetics\nYale University School of Medicine\nThe Lesch Lab \n“Modeling intergenerational epigenetic inheritance of disease phenotypes in mice” \nTrainee Talk:\nJordan Harris\nMD/PhD Candidate\nKambayashi Lab \n“The microbiota and immune system transgenerationally promote phenotypic diversity in offspring” \nHosted by Colin Conine\, Ph.D.
URL:https://epigenetics.upenndev.pendari.com/event/bluma-lesch-m-d-ph-d-yale-jordan-harris-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/png:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/05/YSM3819_0336_B_Lesch-MS_2-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230511T160000
DTEND;TZID=America/New_York:20230511T170000
DTSTAMP:20230504T103527Z
CREATED:20230504T103527Z
LAST-MODIFIED:20230504T103527Z
UID:12493-1683820800-1683824400@epigenetics.upenndev.pendari.com
SUMMARY:At-Large Pilot Grant Talks - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Please join us for a special edition of the Penn Epigenetics Institute Monthly Seminar Series on Thursday\, May 11 from 4:00pm – 5:00pm\, featuring the awardees of the 2023 Epigenetics Institute At-Large Pilot Grants. Hear updates on exciting research in progress: \nGeorge Burslem\, Ph.D. & Andrey Poleshko\, Ph.D.\nUnbiased Probe Discovery for Epigenetics Reprogramming \nWanding Zhou\, Ph.D.\, Rahul Kohli\, M.D.\, Ph.D. & Marisa Bartolomei\, Ph.D.\nComprehensive resolution of epigenome diversity using the ternary-code DNA modification \nErica Korb\, Ph.D. & George Burslem\, Ph.D.\nDeveloping tools to examine the role and regulation of histone crotonylation in the brain \nJoin us in person in 9-146 Smilow (food and beverages provided) or online via the Zoom link below. \nZoom Meeting \nhttps://pennmedicine.zoom.us/j/92913364063?pwd=ZUNqTFo0bEZzSmR1UGcwQnc3bzdkZz09 \nMeeting ID: 929 1336 4063 \nPasscode: 397266
URL:https://epigenetics.upenndev.pendari.com/event/at-large-pilot-grant-talks-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/png:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/05/Monthly-Seminar-Banner-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230511T160000
DTEND;TZID=America/New_York:20230511T170000
DTSTAMP:20230504T103527Z
CREATED:20230504T103527Z
LAST-MODIFIED:20230504T103527Z
UID:14723-1683820800-1683824400@epigenetics.upenndev.pendari.com
SUMMARY:At-Large Pilot Grant Talks - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Please join us for a special edition of the Penn Epigenetics Institute Monthly Seminar Series on Thursday\, May 11 from 4:00pm – 5:00pm\, featuring the awardees of the 2023 Epigenetics Institute At-Large Pilot Grants. Hear updates on exciting research in progress: \nGeorge Burslem\, Ph.D. & Andrey Poleshko\, Ph.D.\nUnbiased Probe Discovery for Epigenetics Reprogramming \nWanding Zhou\, Ph.D.\, Rahul Kohli\, M.D.\, Ph.D. & Marisa Bartolomei\, Ph.D.\nComprehensive resolution of epigenome diversity using the ternary-code DNA modification \nErica Korb\, Ph.D. & George Burslem\, Ph.D.\nDeveloping tools to examine the role and regulation of histone crotonylation in the brain \nJoin us in person in 9-146 Smilow (food and beverages provided) or online via the Zoom link below. \nZoom Meeting \nhttps://pennmedicine.zoom.us/j/92913364063?pwd=ZUNqTFo0bEZzSmR1UGcwQnc3bzdkZz09 \nMeeting ID: 929 1336 4063 \nPasscode: 397266
URL:https://epigenetics.upenndev.pendari.com/event/at-large-pilot-grant-talks-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/png:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/05/Monthly-Seminar-Banner-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230413T160000
DTEND;TZID=America/New_York:20230413T170000
DTSTAMP:20230405T113220Z
CREATED:20230405T113220Z
LAST-MODIFIED:20230405T113220Z
UID:12451-1681401600-1681405200@epigenetics.upenndev.pendari.com
SUMMARY:Bing Yao\, Ph.D. (Emory) & Ting Zhao\, Ph.D. - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Bing Yao\, Ph.D.\nAssistant Professor | Department of Human Genetics\nEmory University School of Medicine\nThe Yao Lab\n** Hosted by Zhaolan (Joe) Zhou\, Ph.D. \nTrainee Talk:\nTing Zhao\, Ph.D.\nPostdoctoral Fellow\nSong Lab
URL:https://epigenetics.upenndev.pendari.com/event/bing-yao-ph-d-emory-ting-zhou-ph-d-hybrid-epigenetics-monthly-seminar-series/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/png:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/04/Bing-Yao.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230413T160000
DTEND;TZID=America/New_York:20230413T170000
DTSTAMP:20230405T113220Z
CREATED:20230405T113220Z
LAST-MODIFIED:20230405T113220Z
UID:14722-1681401600-1681405200@epigenetics.upenndev.pendari.com
SUMMARY:Bing Yao\, Ph.D. (Emory) & Ting Zhao\, Ph.D. - Hybrid Epigenetics Monthly Seminar Series
DESCRIPTION:Bing Yao\, Ph.D.\nAssistant Professor | Department of Human Genetics\nEmory University School of Medicine\nThe Yao Lab\n** Hosted by Zhaolan (Joe) Zhou\, Ph.D. \nTrainee Talk:\nTing Zhao\, Ph.D.\nPostdoctoral Fellow\nSong Lab
URL:https://epigenetics.upenndev.pendari.com/event/bing-yao-ph-d-emory-ting-zhou-ph-d-hybrid-epigenetics-monthly-seminar-series-2/
CATEGORIES:Epigenetics Monthly Seminar Series
ATTACH;FMTTYPE=image/png:https://epigenetics.upenndev.pendari.com/wp-content/uploads/2023/04/Bing-Yao.png
END:VEVENT
END:VCALENDAR